 Paco Herson
Concepts (495)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Ischemia | 36 | 2025 | 321 | 10.280 |
Why?
| | Heart Arrest | 25 | 2025 | 320 | 5.560 |
Why?
| | TRPM Cation Channels | 12 | 2024 | 77 | 5.410 |
Why?
| | Hippocampus | 23 | 2025 | 873 | 3.510 |
Why?
| | Stroke | 22 | 2025 | 1071 | 3.510 |
Why?
| | Neurons | 31 | 2023 | 1494 | 3.170 |
Why?
| | Neuroprotective Agents | 16 | 2020 | 122 | 3.130 |
Why?
| | Cardiopulmonary Resuscitation | 16 | 2025 | 233 | 2.900 |
Why?
| | Sex Characteristics | 16 | 2024 | 736 | 2.400 |
Why?
| | Cell Death | 16 | 2021 | 354 | 2.120 |
Why?
| | Purkinje Cells | 7 | 2019 | 71 | 2.060 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 7 | 2024 | 185 | 1.820 |
Why?
| | Recovery of Function | 6 | 2025 | 642 | 1.790 |
Why?
| | Mice, Inbred C57BL | 48 | 2025 | 5455 | 1.680 |
Why?
| | CA1 Region, Hippocampal | 7 | 2024 | 51 | 1.620 |
Why?
| | Animals | 97 | 2025 | 35391 | 1.430 |
Why?
| | Gonadal Steroid Hormones | 5 | 2025 | 132 | 1.410 |
Why?
| | Mice | 64 | 2025 | 16961 | 1.400 |
Why?
| | Androgens | 8 | 2014 | 177 | 1.380 |
Why?
| | Long-Term Potentiation | 8 | 2025 | 196 | 1.240 |
Why?
| | Ischemia | 5 | 2022 | 406 | 1.210 |
Why?
| | Neuroprotection | 3 | 2020 | 39 | 1.170 |
Why?
| | Receptors, GABA-A | 5 | 2024 | 126 | 1.170 |
Why?
| | Disease Models, Animal | 24 | 2022 | 4078 | 1.150 |
Why?
| | Peptide Fragments | 2 | 2021 | 693 | 1.050 |
Why?
| | Signal Transduction | 11 | 2024 | 4931 | 1.020 |
Why?
| | Infarction, Middle Cerebral Artery | 12 | 2023 | 39 | 0.980 |
Why?
| | Poly(ADP-ribose) Polymerases | 4 | 2013 | 94 | 0.940 |
Why?
| | Reperfusion Injury | 8 | 2020 | 272 | 0.920 |
Why?
| | Hypothermia, Induced | 3 | 2016 | 76 | 0.920 |
Why?
| | Male | 71 | 2025 | 63670 | 0.880 |
Why?
| | Small-Conductance Calcium-Activated Potassium Channels | 5 | 2014 | 10 | 0.870 |
Why?
| | Calcium | 10 | 2022 | 1212 | 0.830 |
Why?
| | Brain Injuries, Traumatic | 4 | 2023 | 341 | 0.820 |
Why?
| | Brain Injuries | 5 | 2021 | 466 | 0.780 |
Why?
| | Brain | 13 | 2024 | 2673 | 0.770 |
Why?
| | Thrombosis | 3 | 2022 | 348 | 0.760 |
Why?
| | Patch-Clamp Techniques | 13 | 2019 | 277 | 0.730 |
Why?
| | Cognition | 3 | 2019 | 1129 | 0.710 |
Why?
| | Sex Factors | 11 | 2024 | 1970 | 0.700 |
Why?
| | Excitatory Postsynaptic Potentials | 3 | 2016 | 119 | 0.690 |
Why?
| | Neuronal Plasticity | 8 | 2023 | 279 | 0.680 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 4 | 2020 | 211 | 0.670 |
Why?
| | Cerebellum | 4 | 2011 | 218 | 0.670 |
Why?
| | Pregnanolone | 2 | 2011 | 33 | 0.650 |
Why?
| | Brain-Derived Neurotrophic Factor | 4 | 2019 | 110 | 0.650 |
Why?
| | Estradiol | 5 | 2018 | 494 | 0.640 |
Why?
| | Potassium Channels | 8 | 2003 | 149 | 0.640 |
Why?
| | Nogo Proteins | 1 | 2019 | 9 | 0.630 |
Why?
| | Neural Inhibition | 3 | 2024 | 158 | 0.590 |
Why?
| | Adult Stem Cells | 1 | 2018 | 39 | 0.570 |
Why?
| | Nerve Regeneration | 1 | 2018 | 62 | 0.570 |
Why?
| | Guideline Adherence | 1 | 2022 | 527 | 0.560 |
Why?
| | Cognitive Dysfunction | 2 | 2019 | 346 | 0.560 |
Why?
| | Long-Term Synaptic Depression | 2 | 2018 | 56 | 0.540 |
Why?
| | Estrogens | 5 | 2013 | 347 | 0.540 |
Why?
| | Nervous System Diseases | 1 | 2019 | 251 | 0.530 |
Why?
| | Neurogenesis | 1 | 2018 | 126 | 0.520 |
Why?
| | Female | 44 | 2025 | 68734 | 0.520 |
Why?
| | Cerebrovascular Disorders | 2 | 2024 | 90 | 0.520 |
Why?
| | Neural Stem Cells | 1 | 2018 | 142 | 0.520 |
Why?
| | Aging | 3 | 2019 | 1778 | 0.520 |
Why?
| | Mice, Knockout | 11 | 2021 | 2881 | 0.510 |
Why?
| | Clotrimazole | 2 | 2013 | 3 | 0.510 |
Why?
| | Microglia | 5 | 2018 | 232 | 0.490 |
Why?
| | Sirtuin 2 | 1 | 2015 | 24 | 0.490 |
Why?
| | Emergency Medical Services | 1 | 2022 | 522 | 0.490 |
Why?
| | Membrane Glycoproteins | 1 | 2018 | 477 | 0.490 |
Why?
| | Oxygen | 4 | 2012 | 915 | 0.470 |
Why?
| | Cell Culture Techniques | 3 | 2013 | 338 | 0.460 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2018 | 431 | 0.460 |
Why?
| | Tissue Plasminogen Activator | 3 | 2022 | 222 | 0.450 |
Why?
| | Cell Hypoxia | 4 | 2013 | 234 | 0.450 |
Why?
| | Animal Experimentation | 1 | 2014 | 6 | 0.440 |
Why?
| | Naltrexone | 1 | 2015 | 87 | 0.440 |
Why?
| | Kynurenine | 2 | 2025 | 113 | 0.440 |
Why?
| | Inhibitory Postsynaptic Potentials | 2 | 2011 | 40 | 0.430 |
Why?
| | Models, Animal | 2 | 2013 | 378 | 0.430 |
Why?
| | Rats | 18 | 2023 | 5483 | 0.420 |
Why?
| | Cerebral Cortex | 3 | 2021 | 439 | 0.410 |
Why?
| | Potassium Channels, Voltage-Gated | 2 | 2003 | 50 | 0.400 |
Why?
| | Peptides | 3 | 2023 | 926 | 0.390 |
Why?
| | Ion Channels | 4 | 2004 | 133 | 0.390 |
Why?
| | Magnetic Fields | 3 | 2022 | 22 | 0.360 |
Why?
| | Synapses | 4 | 2021 | 396 | 0.350 |
Why?
| | Hydrogen Peroxide | 4 | 2020 | 317 | 0.340 |
Why?
| | Oxidative Stress | 7 | 2020 | 1266 | 0.340 |
Why?
| | Memory | 3 | 2023 | 266 | 0.330 |
Why?
| | Action Potentials | 7 | 2022 | 485 | 0.330 |
Why?
| | Adrenergic alpha-2 Receptor Agonists | 3 | 2014 | 24 | 0.330 |
Why?
| | Progesterone | 3 | 2010 | 245 | 0.320 |
Why?
| | Dexmedetomidine | 3 | 2014 | 43 | 0.320 |
Why?
| | Age Factors | 5 | 2021 | 3152 | 0.320 |
Why?
| | Drug Delivery Systems | 2 | 2022 | 333 | 0.310 |
Why?
| | Rats, Sprague-Dawley | 9 | 2023 | 2395 | 0.310 |
Why?
| | Cells, Cultured | 10 | 2018 | 4084 | 0.300 |
Why?
| | Calcium Channels, T-Type | 2 | 2022 | 94 | 0.300 |
Why?
| | Immunohistochemistry | 7 | 2016 | 1685 | 0.300 |
Why?
| | Glucose | 7 | 2014 | 1002 | 0.300 |
Why?
| | Ion Channel Gating | 6 | 2004 | 94 | 0.300 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2014 | 1058 | 0.290 |
Why?
| | NAD | 2 | 1999 | 75 | 0.290 |
Why?
| | Sepsis | 3 | 2019 | 575 | 0.290 |
Why?
| | Humans | 36 | 2025 | 129625 | 0.280 |
Why?
| | HEK293 Cells | 3 | 2020 | 698 | 0.280 |
Why?
| | Memory Disorders | 2 | 2019 | 168 | 0.270 |
Why?
| | Time Factors | 12 | 2025 | 6555 | 0.270 |
Why?
| | Brain Infarction | 3 | 2016 | 23 | 0.270 |
Why?
| | Tryptophan | 2 | 2025 | 177 | 0.260 |
Why?
| | Colloids | 2 | 2017 | 57 | 0.260 |
Why?
| | Dose-Response Relationship, Drug | 5 | 2019 | 2011 | 0.250 |
Why?
| | Dihydrotestosterone | 5 | 2013 | 41 | 0.250 |
Why?
| | Protective Agents | 2 | 2019 | 39 | 0.240 |
Why?
| | Military Personnel | 2 | 2023 | 521 | 0.230 |
Why?
| | Paraplegia | 2 | 2015 | 57 | 0.220 |
Why?
| | GABAergic Neurons | 1 | 2024 | 29 | 0.220 |
Why?
| | Myelin Proteins | 3 | 2016 | 43 | 0.220 |
Why?
| | Epoxide Hydrolases | 2 | 2013 | 13 | 0.210 |
Why?
| | Oxidants | 2 | 2020 | 109 | 0.210 |
Why?
| | Receptors, Adrenergic, alpha-2 | 2 | 2013 | 17 | 0.210 |
Why?
| | Olfactory Receptor Neurons | 1 | 2004 | 68 | 0.210 |
Why?
| | Calmodulin | 2 | 2019 | 76 | 0.210 |
Why?
| | Glycosaminoglycans | 1 | 2023 | 84 | 0.210 |
Why?
| | Spinocerebellar Degenerations | 1 | 2003 | 5 | 0.210 |
Why?
| | Potassium Channels, Calcium-Activated | 4 | 2004 | 11 | 0.210 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 2 | 2013 | 42 | 0.210 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2023 | 27 | 0.210 |
Why?
| | Smell | 1 | 2004 | 138 | 0.210 |
Why?
| | Orchiectomy | 3 | 2013 | 67 | 0.210 |
Why?
| | Corpus Striatum | 4 | 2016 | 158 | 0.200 |
Why?
| | Pneumonia | 2 | 2021 | 617 | 0.200 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2023 | 61 | 0.200 |
Why?
| | Spinal Cord Ischemia | 2 | 2013 | 56 | 0.200 |
Why?
| | Spinal Cord | 3 | 2014 | 353 | 0.200 |
Why?
| | Cerebrovascular Circulation | 1 | 2024 | 228 | 0.200 |
Why?
| | Blood-Brain Barrier | 2 | 2022 | 131 | 0.200 |
Why?
| | Behavior, Animal | 3 | 2018 | 505 | 0.200 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2023 | 79 | 0.200 |
Why?
| | Cerebral Infarction | 1 | 2022 | 42 | 0.200 |
Why?
| | Heparitin Sulfate | 2 | 2019 | 42 | 0.200 |
Why?
| | Primary Cell Culture | 2 | 2013 | 164 | 0.200 |
Why?
| | Single-Cell Analysis | 1 | 2024 | 274 | 0.190 |
Why?
| | Myelin Sheath | 3 | 2023 | 160 | 0.190 |
Why?
| | Metabolomics | 2 | 2024 | 653 | 0.190 |
Why?
| | Emergency Medical Dispatch | 1 | 2022 | 6 | 0.190 |
Why?
| | Phosphorylation | 4 | 2023 | 1713 | 0.190 |
Why?
| | Plasminogen | 1 | 2021 | 31 | 0.190 |
Why?
| | Information Systems | 1 | 2022 | 61 | 0.190 |
Why?
| | Benzimidazoles | 2 | 2014 | 162 | 0.190 |
Why?
| | Spinal Cord Injuries | 2 | 2015 | 194 | 0.190 |
Why?
| | Receptors, Androgen | 3 | 2013 | 143 | 0.190 |
Why?
| | Organ Culture Techniques | 1 | 2021 | 155 | 0.180 |
Why?
| | Heroin | 1 | 2021 | 30 | 0.180 |
Why?
| | Cell Survival | 6 | 2020 | 1076 | 0.180 |
Why?
| | Blotting, Western | 5 | 2012 | 1206 | 0.180 |
Why?
| | gamma-Aminobutyric Acid | 2 | 2017 | 168 | 0.180 |
Why?
| | Islets of Langerhans | 2 | 1997 | 789 | 0.180 |
Why?
| | Metabolome | 1 | 2024 | 340 | 0.180 |
Why?
| | Presynaptic Terminals | 1 | 2021 | 83 | 0.180 |
Why?
| | Encephalitis | 2 | 2014 | 132 | 0.180 |
Why?
| | Eclampsia | 1 | 2020 | 4 | 0.180 |
Why?
| | Insulinoma | 2 | 1997 | 30 | 0.170 |
Why?
| | Cell-Derived Microparticles | 1 | 2021 | 68 | 0.170 |
Why?
| | Extinction, Psychological | 1 | 2021 | 91 | 0.170 |
Why?
| | Adaptation, Physiological | 1 | 2004 | 514 | 0.170 |
Why?
| | Amyloid beta-Peptides | 1 | 2023 | 211 | 0.170 |
Why?
| | Thalamus | 1 | 2021 | 100 | 0.170 |
Why?
| | Fibrinolysis | 2 | 2021 | 137 | 0.170 |
Why?
| | Death-Associated Protein Kinases | 1 | 2020 | 11 | 0.170 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2020 | 51 | 0.170 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 23 | 0.160 |
Why?
| | Cell Membrane | 2 | 2003 | 734 | 0.160 |
Why?
| | Insulin | 3 | 1999 | 2326 | 0.160 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 949 | 0.160 |
Why?
| | Inhibitory Concentration 50 | 1 | 2019 | 86 | 0.160 |
Why?
| | rho GTP-Binding Proteins | 1 | 2020 | 60 | 0.160 |
Why?
| | Intravital Microscopy | 1 | 2019 | 25 | 0.160 |
Why?
| | Extracellular Vesicles | 1 | 2021 | 129 | 0.160 |
Why?
| | Optical Imaging | 1 | 2019 | 56 | 0.160 |
Why?
| | Fibrinolytic Agents | 1 | 2022 | 262 | 0.160 |
Why?
| | Models, Theoretical | 1 | 2023 | 546 | 0.160 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2019 | 69 | 0.160 |
Why?
| | Axons | 2 | 2018 | 192 | 0.160 |
Why?
| | Mutagenesis | 1 | 2019 | 181 | 0.150 |
Why?
| | Cofilin 1 | 1 | 2018 | 5 | 0.150 |
Why?
| | Oligosaccharides | 1 | 2019 | 57 | 0.150 |
Why?
| | Mice, Transgenic | 6 | 2016 | 2128 | 0.150 |
Why?
| | Drug Design | 1 | 2019 | 158 | 0.150 |
Why?
| | Protein Aggregation, Pathological | 1 | 2018 | 16 | 0.150 |
Why?
| | Calcineurin | 1 | 2019 | 98 | 0.150 |
Why?
| | Nerve Net | 1 | 2021 | 260 | 0.150 |
Why?
| | Biomedical Research | 1 | 2024 | 640 | 0.150 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 545 | 0.150 |
Why?
| | Holoenzymes | 1 | 2018 | 22 | 0.150 |
Why?
| | Thalamic Nuclei | 1 | 2018 | 10 | 0.150 |
Why?
| | Pre-Eclampsia | 1 | 2020 | 188 | 0.150 |
Why?
| | Interleukin-10 | 3 | 2015 | 300 | 0.140 |
Why?
| | Molecular Dynamics Simulation | 1 | 2019 | 217 | 0.140 |
Why?
| | Lateral Ventricles | 1 | 2018 | 36 | 0.140 |
Why?
| | Myelin Proteolipid Protein | 1 | 2018 | 62 | 0.140 |
Why?
| | Membrane Proteins | 2 | 2021 | 1125 | 0.140 |
Why?
| | Intracranial Arterial Diseases | 1 | 2017 | 8 | 0.140 |
Why?
| | Alloxan | 1 | 1997 | 4 | 0.140 |
Why?
| | Heparin | 1 | 2019 | 254 | 0.140 |
Why?
| | Mitochondria | 2 | 2021 | 876 | 0.140 |
Why?
| | Dementia | 1 | 2020 | 225 | 0.140 |
Why?
| | Receptors, AMPA | 2 | 2018 | 140 | 0.140 |
Why?
| | Glutathione | 1 | 1999 | 348 | 0.130 |
Why?
| | Receptors, Glutamate | 1 | 2016 | 22 | 0.130 |
Why?
| | Cerebral Arteries | 1 | 2017 | 60 | 0.130 |
Why?
| | Gene Knockdown Techniques | 2 | 2020 | 317 | 0.130 |
Why?
| | Leukoencephalopathies | 1 | 2016 | 21 | 0.130 |
Why?
| | Actins | 1 | 2018 | 411 | 0.130 |
Why?
| | Pericytes | 1 | 2016 | 28 | 0.130 |
Why?
| | Inflammation | 4 | 2021 | 2750 | 0.130 |
Why?
| | Cations | 3 | 2003 | 79 | 0.130 |
Why?
| | Spleen | 3 | 2015 | 509 | 0.130 |
Why?
| | Collagen Type I | 1 | 2016 | 118 | 0.120 |
Why?
| | Furans | 1 | 2015 | 23 | 0.120 |
Why?
| | Cell Communication | 2 | 2016 | 301 | 0.120 |
Why?
| | Tretinoin | 1 | 2016 | 130 | 0.120 |
Why?
| | Brain Concussion | 1 | 2023 | 549 | 0.120 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2013 | 329 | 0.120 |
Why?
| | Magnetic Resonance Angiography | 1 | 2017 | 234 | 0.120 |
Why?
| | Transfection | 2 | 2016 | 915 | 0.120 |
Why?
| | Arginase | 1 | 2015 | 32 | 0.120 |
Why?
| | Interleukin-1beta | 2 | 2014 | 372 | 0.120 |
Why?
| | Membrane Potentials | 5 | 1999 | 292 | 0.120 |
Why?
| | Calbindins | 1 | 2014 | 5 | 0.120 |
Why?
| | Aged | 6 | 2025 | 22061 | 0.120 |
Why?
| | Neutrophil Activation | 1 | 2015 | 80 | 0.120 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2014 | 28 | 0.120 |
Why?
| | Dizocilpine Maleate | 1 | 2014 | 19 | 0.120 |
Why?
| | Calcium Channel Agonists | 1 | 2014 | 12 | 0.120 |
Why?
| | Mutation | 2 | 2020 | 3717 | 0.110 |
Why?
| | Trauma, Nervous System | 1 | 2014 | 2 | 0.110 |
Why?
| | Toll-Like Receptor 4 | 2 | 2013 | 264 | 0.110 |
Why?
| | Tissue Culture Techniques | 1 | 2014 | 74 | 0.110 |
Why?
| | Quinolines | 1 | 2015 | 156 | 0.110 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2014 | 100 | 0.110 |
Why?
| | Microinjections | 2 | 2011 | 86 | 0.110 |
Why?
| | Nerve Tissue Proteins | 2 | 2016 | 569 | 0.110 |
Why?
| | Lentivirus | 2 | 2011 | 53 | 0.110 |
Why?
| | Cross Infection | 1 | 2016 | 217 | 0.110 |
Why?
| | Practice Guidelines as Topic | 1 | 2022 | 1501 | 0.110 |
Why?
| | Electroencephalography | 1 | 2016 | 409 | 0.110 |
Why?
| | Aortic Diseases | 1 | 2015 | 113 | 0.110 |
Why?
| | Analysis of Variance | 3 | 2015 | 1293 | 0.110 |
Why?
| | CD40 Antigens | 1 | 2014 | 88 | 0.110 |
Why?
| | Body Temperature | 1 | 2014 | 212 | 0.110 |
Why?
| | Arachidonic Acids | 1 | 2013 | 59 | 0.100 |
Why?
| | Immunophenotyping | 1 | 2014 | 311 | 0.100 |
Why?
| | bcl-2-Associated X Protein | 1 | 2013 | 55 | 0.100 |
Why?
| | Embryo, Mammalian | 1 | 2013 | 226 | 0.100 |
Why?
| | Piperidines | 1 | 2014 | 201 | 0.100 |
Why?
| | Immune Tolerance | 1 | 2015 | 356 | 0.100 |
Why?
| | Ovariectomy | 3 | 2025 | 135 | 0.100 |
Why?
| | Glomerular Filtration Barrier | 1 | 2012 | 1 | 0.100 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2013 | 203 | 0.100 |
Why?
| | Testosterone | 3 | 2010 | 372 | 0.100 |
Why?
| | Polymerase Chain Reaction | 3 | 2012 | 1035 | 0.100 |
Why?
| | RNA, Small Interfering | 2 | 2011 | 591 | 0.090 |
Why?
| | Endothelium | 1 | 2012 | 121 | 0.090 |
Why?
| | Microscopy, Immunoelectron | 1 | 2011 | 42 | 0.090 |
Why?
| | Iraq War, 2003-2011 | 2 | 2023 | 127 | 0.090 |
Why?
| | Treatment Outcome | 3 | 2022 | 10219 | 0.090 |
Why?
| | Acute Lung Injury | 1 | 2014 | 280 | 0.090 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 61 | 0.090 |
Why?
| | Afghan Campaign 2001- | 2 | 2023 | 130 | 0.090 |
Why?
| | Pyramidal Cells | 1 | 2011 | 69 | 0.090 |
Why?
| | Up-Regulation | 2 | 2025 | 840 | 0.090 |
Why?
| | Culture Media | 1 | 2011 | 162 | 0.090 |
Why?
| | Retrospective Studies | 7 | 2023 | 14522 | 0.090 |
Why?
| | United States | 3 | 2023 | 13871 | 0.090 |
Why?
| | Biomarkers | 2 | 2025 | 3968 | 0.090 |
Why?
| | Child | 4 | 2019 | 20884 | 0.080 |
Why?
| | Aged, 80 and over | 4 | 2025 | 7052 | 0.080 |
Why?
| | Anesthetics, Inhalation | 1 | 2010 | 27 | 0.080 |
Why?
| | Isoflurane | 1 | 2010 | 27 | 0.080 |
Why?
| | RNA, Messenger | 4 | 2018 | 2708 | 0.080 |
Why?
| | Cell Line | 5 | 2012 | 2784 | 0.080 |
Why?
| | Genetic Vectors | 1 | 2011 | 314 | 0.080 |
Why?
| | Cell Movement | 1 | 2014 | 948 | 0.080 |
Why?
| | Disease Progression | 1 | 2017 | 2627 | 0.080 |
Why?
| | Ischemic Attack, Transient | 1 | 2010 | 60 | 0.080 |
Why?
| | Motor Activity | 2 | 2011 | 676 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 2 | 2011 | 651 | 0.080 |
Why?
| | Neutrophils | 1 | 2015 | 1210 | 0.080 |
Why?
| | In Vitro Techniques | 1 | 2011 | 1087 | 0.080 |
Why?
| | Pregnancy | 3 | 2020 | 6417 | 0.070 |
Why?
| | Oligodendroglia | 2 | 2023 | 167 | 0.070 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2013 | 824 | 0.070 |
Why?
| | Animals, Newborn | 2 | 2023 | 835 | 0.070 |
Why?
| | Risk Assessment | 3 | 2025 | 3262 | 0.070 |
Why?
| | Kidney | 2 | 2012 | 1386 | 0.070 |
Why?
| | Apoptosis | 3 | 2016 | 2492 | 0.070 |
Why?
| | Menopause | 1 | 2010 | 297 | 0.070 |
Why?
| | In Situ Nick-End Labeling | 1 | 2006 | 123 | 0.070 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2011 | 708 | 0.070 |
Why?
| | Acute Kidney Injury | 1 | 2014 | 791 | 0.060 |
Why?
| | Hypoxia-Ischemia, Brain | 1 | 2006 | 33 | 0.060 |
Why?
| | Muscle Denervation | 2 | 2002 | 10 | 0.060 |
Why?
| | Kidney Diseases | 1 | 2010 | 383 | 0.060 |
Why?
| | B-Lymphocytes | 1 | 2011 | 816 | 0.060 |
Why?
| | Tumor Cells, Cultured | 2 | 1997 | 943 | 0.060 |
Why?
| | Middle Aged | 5 | 2025 | 31136 | 0.060 |
Why?
| | Cyclic Nucleotide-Gated Cation Channels | 1 | 2004 | 20 | 0.060 |
Why?
| | Hospital Mortality | 2 | 2021 | 848 | 0.060 |
Why?
| | Electrophysiology | 3 | 2003 | 210 | 0.060 |
Why?
| | Decorin | 1 | 2023 | 7 | 0.060 |
Why?
| | Infarction | 1 | 2023 | 10 | 0.050 |
Why?
| | Chondroitin Sulfates | 1 | 2023 | 35 | 0.050 |
Why?
| | Cyclic AMP | 1 | 2004 | 238 | 0.050 |
Why?
| | Kv1.1 Potassium Channel | 1 | 2003 | 8 | 0.050 |
Why?
| | Genes, Lethal | 1 | 2003 | 29 | 0.050 |
Why?
| | Carbonic Anhydrases | 1 | 2003 | 13 | 0.050 |
Why?
| | Acetazolamide | 1 | 2003 | 24 | 0.050 |
Why?
| | Shal Potassium Channels | 1 | 2003 | 6 | 0.050 |
Why?
| | Databases, Factual | 2 | 2021 | 1269 | 0.050 |
Why?
| | Fasciculation | 1 | 2002 | 1 | 0.050 |
Why?
| | Iraq | 1 | 2023 | 52 | 0.050 |
Why?
| | Rats, Wistar | 2 | 2017 | 442 | 0.050 |
Why?
| | Risk Factors | 3 | 2025 | 9786 | 0.050 |
Why?
| | Afghanistan | 1 | 2023 | 70 | 0.050 |
Why?
| | Spatial Memory | 1 | 2022 | 24 | 0.050 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 144 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2024 | 427 | 0.050 |
Why?
| | Muscle, Skeletal | 2 | 2002 | 1613 | 0.050 |
Why?
| | Models, Neurological | 1 | 2004 | 242 | 0.050 |
Why?
| | Tolbutamide | 2 | 1999 | 4 | 0.050 |
Why?
| | Fibrin Clot Lysis Time | 1 | 2021 | 9 | 0.050 |
Why?
| | Muscular Diseases | 1 | 2002 | 107 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2014 | 432 | 0.050 |
Why?
| | Hypnotics and Sedatives | 1 | 2023 | 175 | 0.050 |
Why?
| | Myelin-Oligodendrocyte Glycoprotein | 2 | 2011 | 50 | 0.050 |
Why?
| | Self Administration | 1 | 2021 | 120 | 0.040 |
Why?
| | Aorta, Thoracic | 2 | 2013 | 263 | 0.040 |
Why?
| | Synaptic Transmission | 1 | 2003 | 272 | 0.040 |
Why?
| | Adoptive Transfer | 2 | 2011 | 218 | 0.040 |
Why?
| | Swine | 1 | 2023 | 764 | 0.040 |
Why?
| | Tumor Necrosis Factors | 1 | 2020 | 10 | 0.040 |
Why?
| | Inflammation Mediators | 2 | 2013 | 505 | 0.040 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2001 | 187 | 0.040 |
Why?
| | Neurotoxins | 1 | 2020 | 28 | 0.040 |
Why?
| | Nucleus Accumbens | 1 | 2021 | 126 | 0.040 |
Why?
| | Stress, Physiological | 1 | 2003 | 414 | 0.040 |
Why?
| | Air Ambulances | 1 | 2020 | 32 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2020 | 223 | 0.040 |
Why?
| | Dendritic Spines | 1 | 2020 | 64 | 0.040 |
Why?
| | Thapsigargin | 1 | 1999 | 19 | 0.040 |
Why?
| | Cesium | 1 | 1999 | 20 | 0.040 |
Why?
| | Ion Transport | 1 | 1999 | 62 | 0.040 |
Why?
| | Lymph Nodes | 2 | 2011 | 472 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 2003 | 1207 | 0.040 |
Why?
| | Recurrence | 1 | 2021 | 1011 | 0.040 |
Why?
| | Barium | 1 | 1997 | 28 | 0.040 |
Why?
| | Oligodendrocyte Precursor Cells | 1 | 2018 | 21 | 0.040 |
Why?
| | Glutamic Acid | 1 | 2020 | 234 | 0.040 |
Why?
| | Resuscitation | 1 | 2020 | 237 | 0.030 |
Why?
| | Thiourea | 1 | 1997 | 39 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2019 | 250 | 0.030 |
Why?
| | Magnesium | 1 | 1997 | 154 | 0.030 |
Why?
| | Seizures | 1 | 2020 | 401 | 0.030 |
Why?
| | Free Radical Scavengers | 1 | 1997 | 82 | 0.030 |
Why?
| | Kinetics | 2 | 1997 | 1645 | 0.030 |
Why?
| | Oligopeptides | 1 | 1999 | 258 | 0.030 |
Why?
| | Exons | 1 | 2018 | 342 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2018 | 285 | 0.030 |
Why?
| | Niacinamide | 1 | 1997 | 75 | 0.030 |
Why?
| | Protein Domains | 1 | 2018 | 256 | 0.030 |
Why?
| | Inpatients | 1 | 2021 | 475 | 0.030 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2016 | 45 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2018 | 388 | 0.030 |
Why?
| | Protein Transport | 1 | 2018 | 429 | 0.030 |
Why?
| | Mice, Inbred ICR | 1 | 2016 | 111 | 0.030 |
Why?
| | Heme Oxygenase-1 | 1 | 2016 | 62 | 0.030 |
Why?
| | Hypoxia | 2 | 2014 | 1084 | 0.030 |
Why?
| | Glutathione Transferase | 1 | 2016 | 102 | 0.030 |
Why?
| | Glucose Transporter Type 1 | 1 | 2016 | 50 | 0.030 |
Why?
| | Adult | 2 | 2021 | 35599 | 0.030 |
Why?
| | Biological Transport | 1 | 2017 | 404 | 0.030 |
Why?
| | Cell Polarity | 1 | 1997 | 139 | 0.030 |
Why?
| | Stromal Cells | 1 | 2016 | 106 | 0.030 |
Why?
| | Cytokines | 2 | 2014 | 2021 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2021 | 749 | 0.030 |
Why?
| | Cysteine | 1 | 1997 | 195 | 0.030 |
Why?
| | Estrogen Receptor alpha | 2 | 2010 | 130 | 0.030 |
Why?
| | Adolescent | 3 | 2021 | 20412 | 0.030 |
Why?
| | Receptors, Estrogen | 2 | 2012 | 422 | 0.030 |
Why?
| | Functional Laterality | 1 | 2016 | 222 | 0.030 |
Why?
| | Pharmaceutical Preparations | 1 | 2017 | 171 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 1997 | 479 | 0.030 |
Why?
| | Neurologic Examination | 1 | 2015 | 114 | 0.030 |
Why?
| | T-Lymphocytes | 2 | 2015 | 1936 | 0.030 |
Why?
| | California | 1 | 2016 | 400 | 0.030 |
Why?
| | Colorado | 1 | 2025 | 4404 | 0.030 |
Why?
| | Nanostructures | 1 | 2016 | 100 | 0.030 |
Why?
| | Blood Vessels | 1 | 2016 | 187 | 0.030 |
Why?
| | Hindlimb | 1 | 2015 | 120 | 0.030 |
Why?
| | Chronic Disease | 1 | 2021 | 1720 | 0.030 |
Why?
| | Locomotion | 1 | 2015 | 100 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 1997 | 593 | 0.030 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2014 | 171 | 0.030 |
Why?
| | Hematoxylin | 1 | 2013 | 6 | 0.030 |
Why?
| | Eosine Yellowish-(YS) | 1 | 2013 | 10 | 0.030 |
Why?
| | Cohort Studies | 1 | 2024 | 5426 | 0.030 |
Why?
| | Fluoresceins | 1 | 2013 | 47 | 0.030 |
Why?
| | Constriction | 1 | 2013 | 45 | 0.030 |
Why?
| | CREB-Binding Protein | 1 | 2013 | 27 | 0.030 |
Why?
| | Protein Binding | 1 | 2020 | 2124 | 0.030 |
Why?
| | Chalcones | 1 | 2013 | 9 | 0.030 |
Why?
| | Movement | 1 | 2016 | 270 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2003 | 2542 | 0.030 |
Why?
| | Arginine | 1 | 2015 | 263 | 0.030 |
Why?
| | Odds Ratio | 1 | 2016 | 1019 | 0.030 |
Why?
| | Ligation | 1 | 2013 | 87 | 0.030 |
Why?
| | Apamin | 2 | 2004 | 6 | 0.030 |
Why?
| | Mice, Inbred C3H | 1 | 2013 | 272 | 0.030 |
Why?
| | Hypoglycemic Agents | 2 | 1999 | 1221 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1499 | 0.020 |
Why?
| | Fluorescein-5-isothiocyanate | 1 | 2012 | 37 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 234 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 1947 | 0.020 |
Why?
| | Proteins | 1 | 1997 | 944 | 0.020 |
Why?
| | Kidney Glomerulus | 1 | 2012 | 109 | 0.020 |
Why?
| | Fibronectins | 1 | 2012 | 123 | 0.020 |
Why?
| | Comorbidity | 1 | 2016 | 1547 | 0.020 |
Why?
| | Lymphocyte Subsets | 1 | 2011 | 84 | 0.020 |
Why?
| | Receptors, CCR7 | 1 | 2011 | 28 | 0.020 |
Why?
| | Logistic Models | 1 | 2016 | 1986 | 0.020 |
Why?
| | Receptors, CCR5 | 1 | 2011 | 57 | 0.020 |
Why?
| | Hyaluronan Receptors | 1 | 2011 | 97 | 0.020 |
Why?
| | Mice, SCID | 1 | 2011 | 350 | 0.020 |
Why?
| | Blood | 1 | 2011 | 105 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2012 | 312 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2010 | 90 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2011 | 402 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2018 | 2373 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2011 | 419 | 0.020 |
Why?
| | Aromatase | 1 | 2010 | 31 | 0.020 |
Why?
| | Kidney Cortex | 1 | 2010 | 25 | 0.020 |
Why?
| | Aromatase Inhibitors | 1 | 2010 | 51 | 0.020 |
Why?
| | Blood Urea Nitrogen | 1 | 2010 | 53 | 0.020 |
Why?
| | Renal Circulation | 1 | 2010 | 57 | 0.020 |
Why?
| | Acute-Phase Proteins | 1 | 2010 | 67 | 0.020 |
Why?
| | Lipocalins | 1 | 2010 | 36 | 0.020 |
Why?
| | Estrogen Receptor beta | 1 | 2010 | 38 | 0.020 |
Why?
| | Oncogene Proteins | 1 | 2010 | 55 | 0.020 |
Why?
| | Exploratory Behavior | 1 | 2010 | 88 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2013 | 877 | 0.020 |
Why?
| | Lipocalin-2 | 1 | 2010 | 76 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2013 | 482 | 0.020 |
Why?
| | Castration | 1 | 2009 | 14 | 0.020 |
Why?
| | Blood Chemical Analysis | 1 | 2010 | 97 | 0.020 |
Why?
| | Androgen Receptor Antagonists | 1 | 2009 | 34 | 0.020 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2010 | 209 | 0.020 |
Why?
| | Androgen Antagonists | 1 | 2009 | 79 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1202 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 4894 | 0.020 |
Why?
| | Creatinine | 1 | 2010 | 490 | 0.020 |
Why?
| | Wound Healing | 1 | 2010 | 307 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2011 | 1159 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 712 | 0.020 |
Why?
| | Autoimmunity | 1 | 2011 | 863 | 0.020 |
Why?
| | Pediatrics | 1 | 2013 | 1056 | 0.020 |
Why?
| | Infant | 1 | 2018 | 8995 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 12455 | 0.010 |
Why?
| | Child, Preschool | 1 | 2018 | 10490 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2004 | 297 | 0.010 |
Why?
| | Evoked Potentials | 1 | 2004 | 126 | 0.010 |
Why?
| | COS Cells | 1 | 2003 | 186 | 0.010 |
Why?
| | Blood Pressure | 1 | 2010 | 1736 | 0.010 |
Why?
| | Intracellular Membranes | 1 | 2003 | 83 | 0.010 |
Why?
| | Myoblasts | 1 | 2003 | 81 | 0.010 |
Why?
| | Genes, Reporter | 1 | 2003 | 265 | 0.010 |
Why?
| | Egtazic Acid | 1 | 2001 | 41 | 0.010 |
Why?
| | Sarcoplasmic Reticulum | 1 | 2001 | 45 | 0.010 |
Why?
| | Enhancer Elements, Genetic | 1 | 2003 | 176 | 0.010 |
Why?
| | Cobalt | 1 | 2001 | 50 | 0.010 |
Why?
| | Chelating Agents | 1 | 2001 | 68 | 0.010 |
Why?
| | Potassium | 1 | 2001 | 144 | 0.010 |
Why?
| | Calcium Channels | 1 | 2001 | 164 | 0.010 |
Why?
| | Electromyography | 1 | 2002 | 381 | 0.010 |
Why?
| | Muscle Contraction | 1 | 2002 | 423 | 0.010 |
Why?
| | Base Sequence | 1 | 2003 | 2147 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2003 | 2835 | 0.010 |
Why?
| | Biotransformation | 1 | 1997 | 67 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2003 | 1418 | 0.010 |
Why?
| | Leptin | 1 | 1997 | 220 | 0.010 |
Why?
| | Potassium Channel Blockers | 1 | 1996 | 36 | 0.010 |
Why?
| | Xenopus laevis | 1 | 1996 | 98 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 1996 | 216 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 327 | 0.010 |
Why?
| | Oocytes | 1 | 1996 | 174 | 0.010 |
Why?
| | DNA Primers | 1 | 1996 | 511 | 0.010 |
Why?
|
|
Herson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|